Tested Applications
| Positive IHC detected in | human liver tissue, mouse kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | PANC-1 cells, 4T1 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
22263-1-AP targets Polycystin 1 in IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | polycystic kidney disease 1 (autosomal dominant) |
| Calculated Molecular Weight | 463 kDa |
| GenBank Accession Number | NM_000296 |
| Gene Symbol | Polycystin 1/PKD1 |
| Gene ID (NCBI) | 5310 |
| RRID | AB_2879053 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P98161 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Polycystin 1 (PC1) is also named as PKD1, and Autosomal dominant polycystic kidney disease 1 protein, and belongs to the polycystin family. PKD1 and PKD2 are formed component of a heteromeric calcium-permeable ion channel. PKD1 is considered an orphan, atypical G protein coupled receptor complexed with TRPP2 (Polycystin 2 or PKD2), a Ca2+-permeable ion channel (PMID:27214281). PKD1 is involved in renal tubulogenesis (PMID:12482949).
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for Polycystin 1 antibody 22263-1-AP | Download protocol |
| IHC protocol for Polycystin 1 antibody 22263-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Polycystin 1 Polyclonal antibody (Cat# 22263-1-AP) has 1 citation to date. It appears in the Journal of Clinical Investigation (IF 14.3), in a 2026 study on comprehensive genomic profiling of triple-negative breast cancer metastases and the role of PKD1 in immunotherapy resistance. The associated research field is oncology, specifically breast cancer genomics and immunotherapy. The antibody was applied in IHC using mouse samples.
| Species | Application | Title |
|---|---|---|
J Clin Invest Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance. |









